Novo Nordisk unveiled its latest data for a weight-loss drug candidate, but shares of the maker of Wegovy and Ozempic tumbled ...

Omnicom's $13.5 billion acquisition of rival Interpublic can move forward on the condition the new company does not enter ...

Shares of Scholar Rock Holdings jumped Wednesday after the biopharmaceutical firm reported positive results from a ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...

In adults with obesity and prediabetes, weight loss achieved with tirzepatide was sustained at more than 3 years, according ...

Prescriptions for tirzepatide injections will not be available from GP surgeries or pharmacies in East and North Yorkshire – ...

Danish drugmaker Novo Nordisk has launched its popular weight-loss drug Wegovy in India, months after its rival Mounjaro’s ...

Around 220,000 people with "greatest need" are expected to receive Mounjaro, also known as tirzepatide and made by Lilly ...

Estimates suggest around 1.5 million people in the UK are already taking weight loss drugs, which may have been prescribed ...

WEIGHT loss jabs may also help ward off dementia, a new study suggests. Researchers found that semaglutide – the active ...

What happens if you stop GLP-1 weight loss injections like semaglutide and tirzepatide? Dr Bernard Tan from Bay Medical ...